15.04.2019 08:00:02
|
DGAP-News: CompuGroup Medical SE: Upcoming changes to the CGM Management Board
DGAP-News: CompuGroup Medical SE / Key word(s): Personnel Koblenz, April 15th, 2019. Klaus Esser, Chairman of the Supervisory Board, said: "Since 2008, Christian has played a key role in our executive leadership team and made a big contribution to the success of CGM. During his tenure, we have expanded our geographic and healthcare sector footprint, quadrupled in size and increased our value tenfold. On behalf of the Supervisory Board, I would like to thank Christian for his outstanding commitment over more than a decade and wish him every success in the future." Frank Gotthardt, Chief Executive Officer, said: "A wholehearted thank you to Christian also from my side. He has played a very important part in the development of CGM since our IPO and ensured financial strength and investor support, which has contributed to our double-digit growth and exceptional market position. CGM is perfectly positioned to seize the great opportunities of the sustainably growing eHealth business in 2019 and in many exciting years to come." Christian B. Teig, Chief Financial Officer, said: "I have been with CGM for almost eleven years and it has been a privilege to be a member of this management board. The company is at an all-time high in financial and operational strength and in a leading position to benefit from the continued digitization of the world's healthcare systems. I am confident that CGM will continue to create significant value for customers, employees and shareholders". The new CFO Michael Rauch comes from the same position in Douglas GmbH, a leading Beauty retailer in Europe with sales of 3.3 billion euro in 21 European countries. During his CFO time Douglas has added more than 500 million euro of sales supported by various acquisitions and has increased operational results by a double-digit percentage. Prior to Douglas he had been working for many years at Henkel, including CFO of Henkel Adhesive and CFO of Henkel Beauty Care division. He has over 20 years of international management experience in finance, having also worked in the U.K., Sweden and China. Michael Rauch, incoming CFO, said: "I look forward to joining a value-driven, experienced leadership team with a clear dedication towards long-term profitable growth and strong cash flow orientation building on a remarkable track record." "Michael is a highly qualified CFO with all the right credentials to support CGM's growth trajectory, both organically and by acquisitions. I look forward to the continued support of a strong CFO and the contributions Michael will make to our exciting growth strategy. Together, we will further develop CGM, shape the future and manifest our position as a global leader in healthcare IT.", Gotthardt concludes. About CompuGroup Medical SE CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of approximately EUR 717 million in 2018, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1 million users, including doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 5,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system. Contact for media representatives t: CompuGroup Medical SE
15.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | CompuGroup Medical SE |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Phone: | +49 (0)261 8000 6200 |
Fax: | +49 (0)261 8000 3200 |
E-mail: | investor@cgm.com |
Internet: | www.cgm.com |
ISIN: | DE0005437305 |
WKN: | 543730 |
Indices: | SDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 799747 |
End of News | DGAP News Service |
|
799747 15.04.2019
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!